We are very excited to announce that the Canadian Spondylitis Association has added a great tool for patients to their website. This tool was developed by our own clinical pharmacist, Carolyn Whiskin. The tool was designed to assist patients with rheumatic autoimmune diseases and better understand the risks of being in a state of active disease vs. receiving advanced therapies that can result in low disease activity or remission. It is important to understand that all treatments approved by Health Canada must demonstrate that the health benefits outweigh any risks. Even with that knowledge, patients need confidence that a treatment makes sense for them, and this tool will help in that process.
Click here to use the Arthritis Treatment Risks tool.
We would love to hear your feedback and hope this is a beneficial resource for you.
Carolyn Whiskin is the Pharmacy Manager for Charlton Health. Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain, and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.
Saphnelo (anifrolumab) is a one-of-a-kind therapy by AstraZeneca for the treatment of moderate to severe…
On December 4, 2023, Health Canada approved Pfizer’s Litfulo (ritlecitinib). Litfulo is a once-daily oral…
Infliximab is a protein-based medication referred to as a biologic that treats many immune-mediated conditions. …
On October 3rd, 2023, Health Canada approved Eli Lilly’s newest biologic for the treatment of…
As February is heart month, today is an excellent occasion to really show why we love our hearts and…
To better serve our Hamilton and area patients, we have expanded and moved our Stoney…